Statement on immunizing agents for the prevention of hepatitis.
D000208:Acute Disease; D000914:Antibodies, Viral / Q000032:analysis; D002170:Canada; D002648:Child; D005260:Female; D006506:Hepatitis A / Q000517:prevention & control*; D006509:Hepatitis B / Q000175:diagnosis / Q000517:prevention & control* / Q000635:transmission; D006510:Hepatitis B Antibodies / Q000032:analysis / Q000627:therapeutic use; D017325:Hepatitis B Vaccines; D006801:Humans; D007116:Immunization, Passive / Q000379:methods*; D007231:Infant, Newborn; D008297:Male; D009784:Occupational Diseases / Q000517:prevention & control; D011247:Pregnancy; D011677:Punctures / Q000009:adverse effects; D012698:Serologic Tests; D013997:Time Factors; D014195:Travel; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use*
D000914:Antibodies, Viral; D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines